Cargando…
Suppression of immune regulatory cells with combined therapy of celecoxib and sunitinib in renal cell carcinoma
OBJECTIVE: To observe the the potential benefit of sunitinib in combination with cyclooxygenase-2(COX-2) inhibitor in renal cell carcinoma therapy. METHODS: 769-p cell lines were treated with sunitinib, celecoxib, or in combination at different concentrations respectively. We investigated the expres...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352087/ https://www.ncbi.nlm.nih.gov/pubmed/27926489 http://dx.doi.org/10.18632/oncotarget.13774 |